Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
United States Oil Fund LP
USO
No Data
No Data
8-K: Kiora Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update
10-Q: Quarterly report
8-K: Kiora Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Results; Company Advances Retinal Disease Pipeline with Two Active Phase 2 Clinical Trials
10-K: FY2025 Annual Report
8-K: Kiora Pharmaceuticals Reports Third Quarter 2025 Results; Company Advances Pipeline with Two Actively Enrolling Phase 2 Clinical Trials for Retinal Diseases
10-Q: Q3 2025 Earnings Report